Cystic Fibrosis Breakthroughs Reshape Pediatric Care as Lung Transplant Volumes Drop Toward Historic Lows

New CF treatments have drastically reduced the need for pediatric lung transplants, though remaining cases are becoming more complex and technically demanding.

By: AXL Media

Published: Apr 22, 2026, 4:13 AM EDT

Source: Information for this report was sourced from International Society for Heart and Lung Transplantation

The Transformation of Pediatric Pulmonology

At the International Society for Heart and Lung Transplantation annual meeting in Toronto, Dr. Christian Benden of Boston Children’s Hospital highlighted a major shift in pediatric respiratory medicine. Historically, cystic fibrosis (CF) was the primary driver for lung transplantation in children, accounting for up to 50% of cases in the United States and nearly 70% in Europe and Australia. However, the development of highly effective modulator therapies that address the underlying protein defects in CF patients has fundamentally altered the clinical landscape. These treatments are now being administered to children as young as two years old, and in some instances, even used in utero to protect the lung health of unborn infants, effectively removing CF as a standard indication for transplant.

A Shrinking Field of Complex Scenarios

The success of medical therapies means that pediatric lung transplantation has become an extremely niche field, with fewer than 100 procedures performed globally in patients under 18 each year. This stands in stark contrast to the nearly 5,000 lung transplants performed annually in adults. At major centers like Boston Children’s Hospital, the volume has dropped to just two or three cases per year. Dr. Benden noted that while the quantity of operations has decreased, the severity of the remaining cases has escalated. The most recent transplants at his institution involved patients who were already on extracorporeal membrane oxygenation (ECMO), a high-level life support system that was once considered an extraordinary measure but is now becoming a routine necessity for the few children who still reach end-stage disease.

Technical Hurdles in Neonatal Transplantation

The physiological challenges inherent in pediatric surgery are further complicated by the small size and multi-system fragility of the recipients. Dr. Benden cited a recent case involving an 11-pound infant, emphasizing the extreme technical precision required by surgical teams. These patients frequently suffer from multi-system disease, requiring complex immunosuppression strategies and rigorous infection management. This high-stakes environment demands a multidisciplinary approach where lung transplant specialists must work in close coordination with heart, liver, and kidney transplant programs to manage the comprehensive...